http://www.acc.org/Feed?clinicalTopicID=5a6b0b97-bb84-467a-9e0b-b9c7e7de4b85 Clinical Topic Feed: Atherosclerotic Disease (CAD/PAD) en /Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/ORBITA-Analysis Patients with lower microvascular resistance (MVR) saw greater placebo-controlled benefit from PCI, according to a retrospective analysis of the ORBITA trial published April 29 in JACC: Cardiovascular Interventions. 1778087340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1777629480000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/27/19/07/ACC26-Coronary-Interventional-Trials Late-breaking clinical trials presented at ACC.26 focusing on coronary interventions included several looking at intravascular guidance in complex, high-risk procedures (IVUS-CHIP), bifurcation lesions (DKCRUSH VIII), and unprotected left main PCI (OPTIMAL). 1777570260000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/28/20/06/noble No significant difference was observed in all-cause mortality at 10 years between PCI and CABG in patients with unprotected left main coronary artery disease (CAD) and no additional complex lesions, according to the final results of the NOBLE study published April 4 in The Lancet. 1777412340000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/22/11/23/POST-SCD-Investigations The community burden of sudden cardiac death (SCD) was the topic of two separate studies presented at HRS 2026 and simultaneously published in JACC. 1776960000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/21/15/23/ACC26-Structural-Intervention-Trials-Offer-Viable-Options Late-breaking clinical trials presented at ACC.26 focusing on structural interventions included the PROTECT H2H trial comparing two embolic protection devices (EPDs) in patients undergoing transcatheter aortic valve implantation (TAVI), the PRO-TAVI trial comparing a strategy of routine PCI with a deferred approach... 1776939000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/15/13/28/eagles-eye-view-15apr2026 In this week’s View, Dr. Eagle explores four recent articles that examine how we care for patients. First, Dr. Eagle looks at a new state-of-the-art review that outlines a multidisciplinary framework for cardiogenic shock survivorship. 1776259800000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/08/14/08/Joint-CCS-Focuses-on-Masters-Athletes Masters athletes, defined as adults over the age of 35 years, with more than 300 minutes per week of exercise training, are driven by performance goals in addition to health goals. For those with abnormal CV findings, diagnostic assessment, treatment options, and exercise prescriptions or restrictions have limited generalizability... 1775658600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1775045460000 Articles and Stories